Stay updated on Pembrolizumab in Refractory Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Refractory Meningioma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision label 'v3.3.2' appears, replacing 'v3.2.0', indicating a site version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:43:46.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the generic government funding and operating status notice from the page; study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:32.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No changes detected; the two screenshots show the same study details page.
    Difference
    0.4%
    Check dated 2025-11-03T20:41:24.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:57:09.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Update indicates a new software release (v3.1.0) replacing the previous v3.0.2—no other substantive content changes are shown.
    Difference
    0.1%
    Check dated 2025-09-29T02:57:26.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:57:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Refractory Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.